SOUTH AFRICA: Health to Seek Extra Billions to Combat HIV/AIDS

Important note: Information in this article was accurate in 2009. The state of the art may have changed since the publication date.

SOUTH AFRICA: Health to Seek Extra Billions to Combat HIV/AIDS

Business Day (South Africa) (11.02.09) - Monday, November 09, 2009
Linda Ensor

South Africa's Department of Health is planning to request a boost in funding for HIV/AIDS treatment based on estimates of the number of people needing antiretroviral therapy, a senior health official said recently. The extra funds would be administered by DOH rather than through the provinces, said Kamy Chetty, the department's acting director-general.

In a budget statement introduced in Parliament, the Treasury Department added 5.5 billion rand (US $741 million) for DOH's antiretroviral treatment program over the next three years. The treasury's revised medium-term budget estimate would bring the conditional grant for treatment to a total of 19.2 billion rand (US $2.6 billion). However, DOH will need an estimated 4 billion more rand (US $539 million), bringing the total over three years to about 23 billion rand (US $3.1 billion). DOH proposes the extra funds be allocated as 2.6 billion rand (US $350 million) for next year, 3.1 billion rand (US $418 million) the following year and then 4 billion rand (US $539 million) the next year.

Chetty stressed that the proposals are still preliminary and based on estimates of patients needing treatment. Under current guidelines, HIV patients become eligible for treatment when their CD4 count falls to 200/cubic millimeter. DOH is studying a model that would initiate treatment earlier - boosting the number of patients in treatment as well as the program's cost. DOH will still have to discuss its estimates with the Treasury Department, Chetty noted.
091109
AD091918

Copyright © 2009 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.

Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.